Rare and unusual case of anti-factor XI antibodies in patient with plasma cell leukemia

ConclusionBoth PCL and anti-factor XI inhibitors are two very rare entities. To the best of our knowledge, this is the first reported case of a factor XI inhibitor arising in the setting of PCL. Factor inhibitors should be suspected in patients whose monoclonal gammopathies are accompanied by bleeding manifestations.
Source: BMC Hematology - Category: Hematology Source Type: research